These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434 [TBL] [Abstract][Full Text] [Related]
5. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818 [TBL] [Abstract][Full Text] [Related]
8. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up. Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107 [TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose. Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928 [TBL] [Abstract][Full Text] [Related]
11. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Hyams DM; Mamounas EP; Petrelli N; Rockette H; Jones J; Wieand HS; Deutsch M; Wickerham L; Fisher B; Wolmark N Dis Colon Rectum; 1997 Feb; 40(2):131-9. PubMed ID: 9075745 [TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561 [TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446 [TBL] [Abstract][Full Text] [Related]
15. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571 [TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310 [TBL] [Abstract][Full Text] [Related]
17. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Chari RS; Tyler DS; Anscher MS; Russell L; Clary BM; Hathorn J; Seigler HF Ann Surg; 1995 Jun; 221(6):778-86; discussion 786-7. PubMed ID: 7794081 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer. Cellier P; Leduc B; Martin L; Vié B; Chevelle C; Vendrely V; Salemkour A; Carrie C; Calais G; Burtin P; Campion L; Boisdron-Celle M; Morel A; Berger V; Gamelin E BMC Cancer; 2011 Mar; 11():98. PubMed ID: 21410976 [TBL] [Abstract][Full Text] [Related]
19. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival. Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462 [TBL] [Abstract][Full Text] [Related]
20. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]